Leonard M Miller Professor and Chairman, Department of Psychiatry and Behavioral Sciences, University Miami

Psychiatry

Charles Nemeroff works in the field of Psychiatry. He went to medical school at University of North Carolina at Chapel Hill School of Medicine. University of North Carolina at Chapel Hill School of Medicine is one of the top medical schools in the US. University of North Carolina at Chapel Hill School of Medicine is ranked 22/2 in Research/PrimaryCare. He over the years received 3 awards: "Elected Member", "Top MD" and "Whos Who in Medicine and Healthcare". Charles Nemeroff is a published doctor as well. He has 98 publications published. The latest was: EFFICACY AND LONG-TERM CLINICAL OUTCOME OF COMORBID POSTTRAUMATIC STRESS DISORDER AND MAJOR DEPRESSIVE DISORDER AFTER ELECTROCONVULSIVE THERAPY. Charles Nemeroff accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• The Links Between Stress and Depression: Psychoneuroendocrinological, Genetic, and EnvironMental Interactions.
• EFFICACY AND LONG-TERM CLINICAL OUTCOME OF COMORBID POSTTRAUMATIC STRESS Disorder AND MAJOR DEPRESSIVE Disorder AFTER ELECTROCONVULSIVE THERAPY.
• The Preeminence of Early Life Trauma as a Risk Factor for Worsened Long-Term Health Outcomes in Women.
• Childhood trauma and METH abuse among men who have sex with men: Implications for intervention.
• Brain activation induced by psychological stress in patients with Schizophrenia.
• The interface of depression and cardiovascular disease: therapeutic implications.
• Striatal dopamine receptor plasticity in neurotensin deficient mice.
• Ellen stover.
• Psychopharmacology and the future of personalized treatment.
• Underestimation of substance abuse in psychiatric patients by conventional hospital screening.
• Variation in the oxytocin receptor gene is associated with increased risk for anxiety, stress and depression in individuals with a history of exposure to early life st...
• Emerging antidepressants to treat major depressive Disorder.
• Interaction of Stress, Corticotropin-Releasing Factor, Arginine Vasopressin and Behaviour.
• The biology of depression in cancer and the relationship between depression and cancer progression.
• Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.
• Depression as a Risk Factor for Cancer: From Pathophysiological Advances to Treatment Implications.
• Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive Disorder treated with venlafaxine extended re...
• The pervasive and persistent neurobiological and clinical aftermath of child abuse and neglect.
• The ups and downs of bipolar Disorder research.
• DECREASED BRAINSTEM AND PUTAMEN SERT BINDING POTENTIAL IN DEPRESSED SUICIDE ATTEMPTERS USING [(11) C]-ZIENT PET IMAGING.
• Differential functional connectivity within an emotion regulation neural network among individuals resilient and susceptible to the depressogenic effects of early life...
• TREATMENT OF DEPRESSION IN CARDIOVASCULAR DISEASE.
• Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.
• Heartache and heartbreak--the link between depression and cardiovascular disease.
• Current treatment options for insomnia.
• Decreased activity in right-hemisphere structures involved in social cognition in siblings discordant for Schizophrenia.
• The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.
• Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal.
• The effects of sertraline on psychopathic traits.
• Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expressi...
• Several stressors fail to reduce adult hippocampal neurogenesis.
• The relationship of depression and diabetes: Pathophysiological and treatment implications.
• Lithium, but not fluoxetine or the corticotropin-releasing factor receptor 1 receptor antagonist R121919, increases cell proliferation in the adult dentate gyrus.
• Metabolic syndrome and neurometabolic asymmetry of hippocampus in adult bonnet monkeys.
• Predictors of Neonatal Hypothalamic-Pituitary-Adrenal Axis Activity at Delivery.
• In the aftermath of tragedy: medical and psychiatric consequences.
• Innovative approach to research training: research colloquium for junior investigators.
• The neurobiology of anxiety Disorders: brain imaging, genetics, and psychoneuroendocrinology.
• Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal corre...
• Neurobiological and psychiatric consequences of child abuse and neglect.
• Early life programming and neurodevelopmental Disorders.
• Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood.
• A novel transgenic mouse for gene-targeting within cells that express corticotropin-releasing factor.
• Changes in the vascular area fraction of the hippocampus and amygdala are induced by prenatal dexamethasone and/or adult stress.
• Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on Depressive symptoms.
• Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.
• Asymmetrical contribution of brain structures to treatment-resistant depression as illustrated by effects of right subgenual cingulum stimulation.
• The neurobiological toll of child abuse and neglect.
• Cardiac arrest and cardiopulmonary resuscitation dysregulates the hypothalamic-pituitary-adrenal axis.
• Lower CSF oxytocin concentrations in women with a history of childhood abuse.
• The role of serotonin in the pathophysiology of depression: as important as ever.
• Exploratory structural equation modeling of resting-state fMRI: applicability of group models to individual subjects.
• Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for...
• Cape Town consensus on posttraumatic stress Disorder.
• Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes.
• Neurobiology of posttraumatic stress Disorder.
• Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.
• CompartMental modeling of 11C-HOMADAM binding to the serotonin transporter in the healthy human brain.
• Novel targets for antidepressant therapies.
• The curiously strong relationship between cardiovascular disease and depression in the elderly.
• Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments.
• An interactive web-based method of outreach to college students at risk for suicide.
• Fostering foster care outcomes: quality of intervention matters in overcoming early adversity.
• Platelet thromboxane A2 secretion in patients with Major depression responsive to electroconvulsive therapy.
• Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress Disorder symptoms in adults.
• Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
• The dexamethasone/corticotropin-releasing factor test in men with Major depression: role of childhood trauma.
• Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene.
• Depression, desperation, and suicidal ideation in college students: results from the American Foundation for Suicide Prevention College Screening Project at Emory Univ...
• The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
• Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.
• Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.
• The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
• Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.
• Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
• Antidepressant drug-drug interactions: clinical relevance and risk management.
• Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
• The role of dopamine in the pathophysiology of depression.
• Prevalence and management of treatment-resistant depression.
• Involvement of neuropeptide systems in Schizophrenia: human studies.
• Upregulation of striatal dopamine-2 receptors in Brattleboro rats with prepulse inhibition deficits.
• The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for Major depression.
• Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation.
• The neural correlates of social anxiety Disorder and response to pharmacotherapy.
• Neurotensin: role in psychiatric and neurological diseases.
• Increased stress-induced inflammatory responses in male patients with Major depression and increased early life stress.
• The diagnosis of Major depression in patients with cancer: a comparative approach.
• Clinicians on the front line: active management of depression and anxiety in primary care.
• VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.
• Maternal-infant response to variable foraging demand in nonhuman primates: effects of timing of stressor on cerebrospinal fluid corticotropin-releasing factor and circ...
• Persistent auditory hallucinations that are unresponsive to antipsychotic drugs.
• Reduced glucocorticoid receptors: consequence or cause of depression?
• Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress Disorder and major depression.
• Genetic analysis of the hypothalamic neurotensin system.
• Ketamine-xylazine-acepromazine anesthesia and postoperative recovery in rats.
• A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with Major depression.
• Advances in the treatment of depression.

Schools

---

• University of North Carolina At Chapel Hill

• North Carolina Memorial Hospital

• Duke University Med Center

Conditions Treated

---

• Adjustment Disorder
• Bipolar Disorder
• Borderline Personality Disorder
• Major Depressive Disorder
• View All

Doctors Specialties

---

• Geriatric Psychiatry
• Psychiatry

Accepted Insurances

---

Awards

---

• Elected Member
• Top MD
• Whos Who in Medicine and Healthcare

Education

---

• Duke University Hospital
• University of North Carolina Hospitals
• University of North Carolina at Chapel Hill School of Medicine

Hospital

---

• University of Miami Hospital

Drug Facts

---

NPI NUMBER		1326228347
NPPES Provider LastName		NEMEROFF
NPPES Provider FirstName		CHARLES
NPPES Provider ZIPCode		331362107
NPPES Provider State		FL
Specialty Description		Psychiatry
Total Claim Count		42.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1326228347
Last Name Of The Provider	NEMEROFF
First Name Of The Provider	CHARLES
View All

Similar Doctors

---

	Dr. Alberto A. Penalver, MD This Doctor is OpenDoctor Recommended.
	Dr. Enrique Diaz, MD This Doctor is OpenDoctor Recommended.
	Dr. Anna R. Rzadkowolsky, MD This Doctor is OpenDoctor Recommended.
	Dr. Luminita E. Luca, MD This Doctor is OpenDoctor Recommended.
	Dr. Rita Abislaiman, MD This Doctor is OpenDoctor Recommended.
	Dr. Ivan A. Hernandez, MD
	Dr. Arnold P. Carter, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog